Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q2 2021 Earnings Conference Call August 4, 2021 5:00 PM ET Company Participants Christine Cassiano - Chief Communications Officer David Chang - President and CEO Rafael Amado - EVP, Research and Development and CMO Eric Schmidt - CFO Conference Call Participants Marc Frahm - Cowen & Company Luca Issi - RBC Salveen Richter - Goldman Sachs Jason Gerberry - Bank of America John Newman - Canaccord Mark Breidenbach - Oppenheimer Reni Benjamin - JMP Securities Raju Prasad ...